Immune thrombocytopenia in children with reference to low income countries
EMHJ-Eastern Mediterranean Health Journal. 2009; 15 (3): 729-737
in English
| IMEMR
| ID: emr-157374
ABSTRACT
Immune thrombocytopenia is a benign and self-limiting disorder. Data about the condition and its incidence from low-income countries is limited. This paper reviews the research about immune thrombocytopenia, comparing low- and high-income countries. Diagnosis is usually based on complete blood count and peripheral smear and, in selected cases, bone marrow aspiration. The disease has a high remission rate both in high- and low-income countries and intracranial haemorrhage is rare. The recommended treatment is simply observation of cases, especially when the platelet count is > 10 000 /mm[3]. If drug therapy is required, oral steroids are the most economical choice
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Incidence
/
Treatment Outcome
/
Immunoglobulins, Intravenous
/
Cost-Benefit Analysis
/
Intracranial Hemorrhages
/
Developing Countries
/
Diagnosis, Differential
/
Glucocorticoids
Type of study:
Incidence study
Limits:
Humans
Language:
English
Journal:
East Mediterr Health J.
Year:
2009
Similar
MEDLINE
...
LILACS
LIS